Company News
Patronus Biotech Gets Ethics Approval, Phase I
Patronus Biotech obtained Bellberry Ethics Committee approval on 19 Oct 2026 for its Phase I trial (NCT07831226) of three VLP malaria vaccines.
The trial will randomise healthy adults at Melbourne’s N
